Skip to main content
SEC Accession #

0001665160-19-000627

Platform Raised on
Filing Date
Deadline Date

Investment Security Details

Submission
C-U
Price of Security
$1.00
Round
Simple Agreement for Future Equity (SAFE)
# Securities
200,000
Capital Type

Other

Max Offering
$1,000,000.00

The amount raised at the time of closing is $255,600.

Price Detail
Pro-rated portion of the total principal value of $200,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.

Investing Platform Detail

Platform Comp
4.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Financial Interest
No

Offering Company Details

Executive Signatory
Charles S. Cotropia
Title
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer
Website
http://www.bioclonetics.com
Employee Count at Offering
3
SEC CIK
1701251
FILE NUMBER
020-23301

Comments